Liabilities of Surface Oncology, Inc. from 31 Dec 2017 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
- Summary
-
Surface Oncology, Inc. quarterly Liabilities in USD history and change rate from 31 Dec 2017 to 30 Jun 2023.
- Surface Oncology, Inc. Liabilities for the quarter ending 30 Jun 2023 was $16,828,000, a 75% decline year-over-year.
- Source SEC data
- View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)
Surface Oncology, Inc. Quarterly Liabilities (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $16,828,000 | -$51,435,000 | -75% | 30 Jun 2023 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $61,177,000 | -$9,516,000 | -13% | 31 Mar 2023 | 10-Q | 04 May 2023 | 2023 | Q1 |
| Q4 2022 | $66,507,000 | -$5,440,000 | -7.6% | 31 Dec 2022 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $68,802,000 | +$11,387,000 | +20% | 30 Sep 2022 | 10-Q | 02 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $68,263,000 | +$10,833,000 | +19% | 30 Jun 2022 | 10-Q | 03 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $70,693,000 | +$14,994,000 | +27% | 31 Mar 2022 | 10-Q | 09 May 2022 | 2022 | Q1 |
| Q4 2021 | $71,947,000 | +$10,556,000 | +17% | 31 Dec 2021 | 8-K | 03 Jul 2023 | ||
| Q3 2021 | $57,415,000 | -$1,191,000 | -2% | 30 Sep 2021 | 10-Q | 04 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $57,430,000 | +$575,000 | +1% | 30 Jun 2021 | 10-Q | 05 Aug 2021 | 2021 | Q2 |
| Q1 2021 | $55,699,000 | +$6,050,000 | +12% | 31 Mar 2021 | 10-Q | 05 May 2021 | 2021 | Q1 |
| Q4 2020 | $61,391,000 | -$13,636,000 | -18% | 31 Dec 2020 | 10-K | 02 Mar 2022 | 2021 | FY |
| Q3 2020 | $58,606,000 | -$11,385,000 | -16% | 30 Sep 2020 | 10-Q | 10 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $56,855,000 | -$13,671,000 | -19% | 30 Jun 2020 | 10-Q | 11 Aug 2020 | 2020 | Q2 |
| Q1 2020 | $49,649,000 | -$20,566,000 | -29% | 31 Mar 2020 | 10-Q | 12 May 2020 | 2020 | Q1 |
| Q4 2019 | $75,027,000 | +$3,824,000 | +5.4% | 31 Dec 2019 | 10-K | 09 Mar 2021 | 2020 | FY |
| Q3 2019 | $69,991,000 | -$10,267,000 | -13% | 30 Sep 2019 | 10-Q | 12 Nov 2019 | 2019 | Q3 |
| Q2 2019 | $70,526,000 | -$9,646,000 | -12% | 30 Jun 2019 | 10-Q | 07 Aug 2019 | 2019 | Q2 |
| Q1 2019 | $70,215,000 | -$14,252,000 | -17% | 31 Mar 2019 | 10-Q | 09 May 2019 | 2019 | Q1 |
| Q4 2018 | $71,203,000 | -$29,048,000 | -29% | 31 Dec 2018 | 10-K | 10 Mar 2020 | 2019 | FY |
| Q3 2018 | $80,258,000 | 30 Sep 2018 | 10-Q | 13 Nov 2018 | 2018 | Q3 | ||
| Q2 2018 | $80,172,000 | 30 Jun 2018 | 10-Q | 14 Aug 2018 | 2018 | Q2 | ||
| Q1 2018 | $84,467,000 | 31 Mar 2018 | 10-Q | 29 May 2018 | 2018 | Q1 | ||
| Q4 2017 | $100,251,000 | 31 Dec 2017 | 10-K | 07 Mar 2019 | 2018 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.